Skip to main content
Signal8

Hull Hans

SEC insider (Form 3/4/5 filer). CIK 0001614876. Chief Business Officer at PLIANT THERAPEUTICS, INC. (PLRX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 23, 2025. Located in SOUTH SAN FRANCISCO, CA.

Companies Hull Hans has filed insider reports for

  • PLIANT THERAPEUTICS, INC. (PLRX): Officer, Chief Business Officer
Hull Hans profile photo

Hull Hans

CIK: 0001614876

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PLIANT THERAPEUTICS, INC. logo
PLRX

PLIANT THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • PLIANT THERAPEUTICS, INC. logo
    PLRX

    PLIANT THERAPEUTICS, INC.

    Jan 23, 2025
    Award
    Direct
    40.2K shares-
  • PLIANT THERAPEUTICS, INC. logo
    PLRX

    PLIANT THERAPEUTICS, INC.

    Jan 17, 2025
    Sale
    Direct
    15.9K shares at avg. $11.20$179K

1-2 of 2